-
21
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
Published 2021-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
22
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
23
GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
24
TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
25
Adjuvants for peptide-based cancer vaccines
Published 2016-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
26
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
27
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
28
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
29
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
30
Selective expression and significance of ACKR2 in lung aerocytes
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
31
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
32
Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
33
PD-1 suppresses human CD38+ circulating Tfr cells and regulates humoral immunity
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
34
Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
35
Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
36
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
37
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slid...
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
38
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
39
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
40
Correction: Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article